BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16846724)

  • 1. Copolymers of pharmaceutical grade lactic acid and sebacic acid: drug release behavior and biocompatibility.
    Modi S; Jain JP; Domb AJ; Kumar N
    Eur J Pharm Biopharm; 2006 Nov; 64(3):277-86. PubMed ID: 16846724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation and release of vancomycin from poly(D,L-lactide-co-glycolide) microspheres.
    Atkins TW; Peacock SJ; Yates DJ
    J Microencapsul; 1998; 15(1):31-44. PubMed ID: 9463805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxy fatty acid based polyanhydride as drug delivery system: synthesis, characterization, in vitro degradation, drug release, and biocompatibility.
    Jain JP; Modi S; Kumar N
    J Biomed Mater Res A; 2008 Mar; 84(3):740-52. PubMed ID: 17635032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ester-anhydride):poly(beta-amino ester) micro- and nanospheres: DNA encapsulation and cellular transfection.
    Pfeifer BA; Burdick JA; Little SR; Langer R
    Int J Pharm; 2005 Nov; 304(1-2):210-9. PubMed ID: 16174553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release.
    Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH
    J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
    Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
    Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro release of model compounds with different hydrophilicity from poly(ester-anhydride) microspheres.
    Jaszcz K
    Acta Pol Pharm; 2013; 70(6):1051-63. PubMed ID: 24383329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine.
    Shelke NB; Aminabhavi TM
    Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
    Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles.
    Tse MT; Blatchford C; Oya Alpar H
    Int J Pharm; 2009 Mar; 370(1-2):33-40. PubMed ID: 19059325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acidic pH on PLGA microsphere degradation and release.
    Zolnik BS; Burgess DJ
    J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.